LabGenomics Co., Ltd. (KOSDAQ:084650)

South Korea flag South Korea · Delayed Price · Currency is KRW
2,395.00
-45.00 (-1.84%)
Aug 14, 2025, 2:39 PM KST
-34.20%
Market Cap 177.06B
Revenue (ttm) 87.90B
Net Income (ttm) -20.16B
Shares Out 74.24M
EPS (ttm) -271.60
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 653,985
Average Volume 1,474,853
Open 2,440.00
Previous Close 2,440.00
Day's Range 2,390.00 - 2,450.00
52-Week Range 1,991.00 - 5,420.00
Beta -0.31
RSI 49.95
Earnings Date Aug 14, 2025

About LabGenomics

LabGenomics Co., Ltd. engages in the research and development of biotechnology products in South Korea. It is also involved in the sale of diagnostic devices. The company was founded in 2002 and is based in Seongnam-si, South Korea. [Read more]

Industry Commercial Physical and Biological Research
Founded 2002
Employees 163
Stock Exchange KOSDAQ
Ticker Symbol 084650
Full Company Profile

Financial Performance

In 2024, LabGenomics's revenue was 85.90 billion, an increase of 20.85% compared to the previous year's 71.08 billion. Losses were -23.80 billion, 409.1% more than in 2023.

Financial Statements

News

There is no news available yet.